Biopathology and Regenerative Medicine Institute (IBIMER)
Patricia Galvez-Martin completed her PhD in 2014, MSc in Drug Development (2008) and MSc in Clinical Trials (2012). She has participated in several clinical trials, with great experience in the pharmaceutical industry, as a qualified person and Quality Control Manager. She is expert in the design and development of new medicines with cells, genes and tissues to treat different pathologies. She is currently working in the biotech company, Bioibérica as the Director of Advanced Therapies Unit.
Biosimilars, Biologics, Biomedicines